Skip to main content

Second Mistrial Announced in a J&J Talc Cancer Suit Retrial

Second Mistrial Announced in a J&J Talc Cancer Suit Retrial

Second Mistrial Announced in a J&J Talc Cancer Suit Retrial

Introduction

A second South Carolina jury failed to reach a verdict in a retrial case filed against talcum powder giant Johnson & Johnson involving claims filed by the family of a victim, who died of mesothelioma in 2017, allegedly due to the asbestos exposure from J&J's talcum powder.

Then 30-year-old victim ran a three-person law firm in Columbia along with her husband. Earlier in May, the Darlington County Court of Common Pleas in Charleston was deadlocked in the first trial against J&J. A lawyer representing the family stated that the plaintiffs were unhappy with the mistrial announcement as J&J refused to take responsibility for the damages caused even when the jury urged the parties to consider settlement.  The company continues to deny the presence of asbestos in its talcum products. This is the fifth time the jury has announced a mistrial in a mesothelioma case against J&J as it failed to reach a verdict or because the plaintiff died.

There are about 11,700 lawsuits against J&J, claiming that the company failed to adequately warn consumers about the carcinogenic asbestos presence in its talc-based products causing mesothelioma and ovarian cancer in several individuals. J&J has consistently declined the hazards of its talcum products and is currently appealing all jury verdicts declared against them.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!